The approval is supported by data from the COBLT study, FDA dockets and public information, and an observational database.
The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback